Registries and Studies

Our registries and studies are designed to evaluate the safety and effectiveness of treatments outside of the clinical trial setting. Learn more about our ongoing dedication to advancing patient care through the generation of real-world data.

Lonapegsomatropin-tcgd

Prescribing Information

An international post-marketing study of the potential long-term safety risks under real-world conditions
about An international post-marketing study of the potential long-term safety risks under real-world conditions
A US non-interventional study to evaluate real-world safety and effectiveness
about A US non-interventional study to evaluate real-world safety and effectiveness

Palopegteriparatide

Prescribing Information

A global pregnancy registry to assess maternal, fetal, and infant outcomes following exposure to palopegteriparatide during pregnancy and breastfeeding
about A global pregnancy registry to assess maternal, fetal, and infant outcomes following exposure to palopegteriparatide during pregnancy and breastfeeding
A study to assess the amount of palopegteriparatide in breast milk of lactating females requiring palopegteriparatide
about A study to assess the amount of palopegteriparatide in breast milk of lactating females requiring palopegteriparatide

Ascendis Pharma does not recommend or endorse using its medications in a way that conflicts with FDA-approved labeling.